Medical information Clinical review pending

Genetic Testing

BCRABL Gene Rearrangement PCR Qualitative Test

Detects the BCR-ABL fusion gene, a key marker for Chronic Myeloid Leukemia (CML) and some other leukemias. This test helps in diagnosis and treatment planning.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Blood sample (usually collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.
Results: Confirm with the laboratory before booking.
Preparation: No special preparation is typically required for this test. However, confirm with the laboratory regarding any specific instructions.

Test priceKSh 10,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the BCRABL Gene Rearrangement PCR Qualitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Suspected Chronic Myeloid Leukemia (CML)
✓Diagnosis of certain types of acute leukemia
✓Monitoring treatment response in CML patients
✓Evaluating unexplained blood count abnormalities
✓Assessing risk in individuals with potential leukemia symptoms
✓Family history of leukemia (consult your doctor)

In plain language

What this test helps you understand

This test is used to detect the presence of the BCR-ABL fusion gene, which is characteristic of Chronic Myeloid Leukemia (CML) and some other leukemias. It aids in diagnosis, prognosis, and monitoring treatment response.

The BCRABL Gene Rearrangement PCR Qualitative Test is a vital diagnostic tool used to identify specific genetic changes linked to certain types of leukemia, most notably Chronic Myeloid Leukemia (CML). This test is essential for confirming a diagnosis, guiding treatment strategies, and monitoring the effectiveness of therapy. It looks for the fusion of the BCR gene (chromosome 22) and the ABL gene (chromosome 9), creating the BCR-ABL fusion gene. The presence of this gene is a hallmark of CML. This test is crucial for healthcare providers to make informed decisions about patient care.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo special preparation is typically required for this test. However, confirm with the laboratory regarding any specific instructions.

SampleBlood sample (usually collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.

MethodologyPolymerase Chain Reaction (PCR) based method to detect the specific BCR-ABL gene rearrangement.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This is a qualitative test, meaning it detects the presence or absence of the BCR-ABL fusion gene, but does not quantify the amount. False negatives can occur if the sample quality is poor or the amount of fusion gene is below the detection limit. False positives are rare but possible. Results should always be interpreted in conjunction with clinical findings and other laboratory tests.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

A positive result indicates the presence of the BCR-ABL fusion gene, which is strongly associated with Chronic Myeloid Leukemia (CML). Further consultation with your doctor is necessary to discuss the implications and next steps.

A negative result means the BCR-ABL fusion gene was not detected in the sample. While this can be reassuring, it does not completely rule out leukemia, especially if clinical suspicion is high. Your doctor will interpret this result in the context of your overall health.

The test requires a blood sample, which involves a small needle prick. Most people find this minimally uncomfortable.

The test is highly accurate for detecting the BCR-ABL fusion gene. However, like all tests, there is a small chance of false positive or false negative results. Your doctor will consider this when interpreting your results.

Yes, home sample collection services may be available. Please contact the laboratory to confirm availability and arrange for collection.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp